Siren, L.L.C.: 13F holdings
CIK 20052452026Q2
| Positions | 116 |
|---|
| Reported value | $4.9bn |
|---|
| Filed | 2026-08-13 |
|---|
Change since last quarter
| Positions | 116 (+16 vs prior quarter) |
|---|
| Reported value | $4.9bn (+37.0%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| SRRK Scholar Rock Holding Corp | 9,575,013 | $526.6m | 10.7% |
| KYMR Kymera Therapeutics Inc | 2,935,830 | $336.7m | 6.8% |
| ERAS Erasca Inc | 11,397,781 | $208.8m | 4.2% |
| MANE Veradermics Inc | 1,655,374 | $203.5m | 4.1% |
| TNGX Tango Therapeutics Inc | 6,179,364 | $193.2m | 3.9% |
| RVMD Revolution Medicines Inc | 900,000 | $168.6m | 3.4% |
| BCAX Bicara Therapeutics Inc | 5,602,970 | $166.4m | 3.4% |
| ARWR Arrowhead Pharmaceuticals Inc | 1,715,476 | $139.8m | 2.8% |
| ONC BeOne Medicines AG | 465,000 | $132.5m | 2.7% |
| EWTX Edgewise Therapeutics Inc | 3,184,629 | $129.4m | 2.6% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2005245")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples